LLY Earnings: Eli Lilly Reports Impressive Q2 Results; Huge Revenue Increase – TipRanks

0
67


  1. LLY Earnings: Eli Lilly Reports Impressive Q2 Results; Huge Revenue Increase  TipRanks
  2. Eli Lilly Stock Surges as Mounjaro and Zepbound Drugs Fuel Sales  The Wall Street Journal
  3. Eli Lilly’s second quarter eases Zepound pricing fears and suggests it’s gaining ground in weight loss race  CNBC
  4. Eli Lilly’s stock leaps after big earnings beat, boosted by strength in Mounjaro and Zepbound sales  MarketWatch
  5. Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion  Investors | Eli Lilly and Company


LEAVE A REPLY

Please enter your comment!
Please enter your name here